Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Medtech 360 | Market Analysis | Japan | 2018

The mature Japanese CRM device market will remain flat through 2026, characterized by low generator unit volume growth, rising ICM procedure volumes, and price erosion. The uptake of premium-priced devices such as CRT devices, leadless pacemakers, and S-ICDs will help mitigate the downward pressure of reimbursement cuts over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the Japanese cardiac rhythm management device market across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…